SCHEMBL13482

SCHEMBL13482

CCCCCCCCN(C)Cc1c(C)noc1-c1ccc(Br)cc1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LSS P48449 3/20 0.35
TDP1 Q9NUW8 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 2/20 0.33
TP53 P04637 2/20 0.33
KDM4E B2RXH2 1/20 0.33
DRD3 P35462 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.31
TSHR P16473 1/20 0.31
ADRB2 P07550 1/20 0.31
NPC1 O15118 1/20 0.31
MAPK1 P28482 1/20 0.31
RAB9A P51151 1/20 0.31
SLC6A9 P48067 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13486 0.88 DRD3 (0.43) ALDH1A1KDM4EDRD3SMN1; SMN2SLC6A9
SCHEMBL10012 0.82 CYP2C9 (0.40) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1743 0.80 L3MBTL1 (0.41) ALDH1A1KDM4EMAPTSMN1; SMN2TSHR
SCHEMBL18597812 0.75 CYP1A2 (0.44) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1185 0.72 CYP1A2 (0.44) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6483 0.71 CYP1A2 (0.43) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL1683 0.71 CYP1A2 (0.43) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL31612505 0.69 KDM4E (0.64) CYP1A2CYP2C19ALDH1A1KDM4EMAPT
SCHEMBL13967 0.69 PPARG (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1KDM4E
SCHEMBL5419 0.69 TDP1 (0.41) TDP1CYP1A2CYP3A4CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041462-A2 POLYCYCLIC COMPOUNDS AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS AMIRA PHARMACEUTICALS, INC. (US) 2011-04-07 WO disclosed